Here are what the editors at HealthDay consider to be the most important developments in Urology for May 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
9.5 Percent Uninsured in U.S. From January Through June 2019
WEDNESDAY, May 27, 2020 (HealthDay News) — A total of 9.5 percent of persons were uninsured from January through June 2019, according to a report published online May 28 by the National Center for Health Statistics.
Links Found Between Leaders of Medical Associations, Industry
THURSDAY, May 28, 2020 (HealthDay News) — There are extensive financial relationships between leaders of U.S. professional medical associations and industry, according to a study published online May 27 in The BMJ.
Only One in Four U.S. Hospitals With ICUs Have Tele-ICU Services
WEDNESDAY, May 27, 2020 (HealthDay News) — In 2018, half of U.S. hospitals had the capacity to conduct telehealth-based outpatient visits, while only one in four had tele-intensive care unit (tele-ICU) capabilities, according to a research letter published online April 30 in the Annals of Internal Medicine.
Abstract/Full Text (subscription or payment may be required)
ACR Updates Guideline for Management of Gout
THURSDAY, May 21, 2020 (HealthDay News) — In an updated American College of Rheumatology guideline, published online May 11 in Arthritis Care & Research, recommendations are presented for the management of gout.
Local-Stage Prostate Cancer Incidence Rates Continue to Drop
WEDNESDAY, May 20, 2020 (HealthDay News) — Prostate cancer incidence rates decreased from 2005 to 2016 for local-stage disease among men aged ≥50 years but increased for regional- and distant-stage disease, according to a study published online May 20 in the Journal of the National Cancer Institute.
Abstract/Full Text (subscription or payment may be required)
High BMI in Childhood May Up Risk for Bladder Cancer as Adult
WEDNESDAY, May 20, 2020 (HealthDay News) — Childhood body mass index (BMI) is positively associated, while childhood height is inversely associated, with the risk for bladder cancer (BC) in adulthood, according to a study published online May 19 in the Annals of Human Biology.
Abstract/Full Text (subscription or payment may be required)
28 Million-Plus Surgeries Could Be Canceled Due to COVID-19
TUESDAY, May 19, 2020 (HealthDay News) — Worldwide, more than 28 million elective surgeries could be canceled or postponed during the 12 weeks of peak disruption due to COVID-19, according to a study published online May 12 in the British Journal of Surgery.
Abstract/Full Text (subscription or payment may be required)
Spending on Primary Care Continues to Lag in the U.S.
TUESDAY, May 19, 2020 (HealthDay News) — Spending on inpatient services, specialty care, and prescriptions together accounted for about two-thirds of the increase in total U.S. health care spending from 2002 to 2016, according to a research letter published online May 18 in JAMA Internal Medicine.
Abstract/Full Text (subscription or payment may be required)
Burnout Comparable Between Millennial, Gen X Residents, Fellows
TUESDAY, May 19, 2020 (HealthDay News) — Millennial and Generation X medical residents and fellows experience similar rates of burnout and have similar levels of empathy, according to a study published online May 5 in Academic Psychiatry.
Abstract/Full Text (subscription or payment may be required)
Most Physicians Have Seen False-Negative COVID-19 Test Results
MONDAY, May 18, 2020 (HealthDay News) — Most physicians believe they have seen false-negative results for a COVID-19 diagnostic test, according to the results of a recent survey.
Addition of Atezolizumab May Aid in Metastatic Urothelial Cancer
FRIDAY, May 15, 2020 (HealthDay News) — For patients with metastatic urothelial carcinoma, the addition of atezolizumab to platinum-based chemotherapy prolongs progression-free survival, according to a study published online May 14 in The Lancet.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Deceased Donor Transplantation Has Dropped Since COVID-19
WEDNESDAY, May 13, 2020 (HealthDay News) — Since the COVID-19 outbreak, there has been a reduction in deceased donor transplantations in France and the United States, according to a research letter published online May 11 in The Lancet.
SARS-CoV-2 Identified in Semen of Men With COVID-19
FRIDAY, May 8, 2020 (HealthDay News) — Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is present in the semen of some patients with COVID-19, including recovering patients, according to a study published online May 7 in JAMA Network Open.
Risk for SARS-CoV-2 Lower for Prostate Cancer Patients on ADT
FRIDAY, May 8, 2020 (HealthDay News) — Among prostate cancer patients, those receiving androgen-deprivation therapy (ADT) versus other treatments have a lower risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, according to a study published online May 6 in the Annals of Oncology.
Testicular Germ Cell Tumor Incidence Increased for All Races/Ethnicities
FRIDAY, May 8, 2020 (HealthDay News) — From 2001 to 2016, the incidence of testicular germ cell tumors increased across all racial/ethnic groups but remained highest among non-Hispanic whites (NHWs), according to a study published online May 8 in Cancer Epidemiology, Biomarkers & Prevention.
Abstract/Full Text (subscription or payment may be required)
UGN-101 Active in Chemoablation of Upper Tract Urothelial Cancer
THURSDAY, May 7, 2020 (HealthDay News) — For patients with low-grade upper tract urothelial cancer, primary chemoablation with intracavitary UGN-101, a mitomycin-containing reverse thermal gel, results in clinically significant disease eradication, according to a study published online April 29 in The Lancet Oncology.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Genomically Targeted Treatment Slows Advanced Prostate Cancer
MONDAY, May 4, 2020 (HealthDay News) — Genomic targeted prostate cancer treatment shows a survival benefit in patients with metastatic castration-resistant prostate cancer, according to a study published online April 28 in the New England Journal of Medicine.
Abstract/Full Text (subscription or payment may be required)
Copyright © 2020 ScoutNews, LLC. All rights reserved.
